Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Oncolytic HSV-1 rRp450 |
| Trade Name | |
| Synonyms | rRp450 |
| Drug Descriptions |
Oncolytic HSV-1 rRp450 is an engineered oncolytic type-I herpes simplex virus 1 (HSV-1) that encodes CYP2B1, which activates cancer prodrugs including cyclophosphamide and enhances sensitivity to chemotherapy agents, potentially resulting in increased tumor cell lysis and reduced metastases (PMID: 12209705). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C90563 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cyclophosphamide + Oncolytic HSV-1 rRp450 | Cyclophosphamide Oncolytic HSV-1 rRp450 | 0 | 0 |
| Oncolytic HSV-1 rRp450 | Oncolytic HSV-1 rRp450 | 0 | 1 |